Cargando…

Fertility preservation in female classic galactosemia patients

Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there a...

Descripción completa

Detalles Bibliográficos
Autores principales: van Erven, Britt, Gubbels, Cynthia S, van Golde, Ron J, Dunselman, Gerard A, Derhaag, Josien G, de Wert, Guido, Geraedts, Joep P, Bosch, Annet M, Treacy, Eileen P, Welt, Corrine K, Berry, Gerard T, Rubio-Gozalbo, M Estela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718676/
https://www.ncbi.nlm.nih.gov/pubmed/23866841
http://dx.doi.org/10.1186/1750-1172-8-107
_version_ 1782277800891252736
author van Erven, Britt
Gubbels, Cynthia S
van Golde, Ron J
Dunselman, Gerard A
Derhaag, Josien G
de Wert, Guido
Geraedts, Joep P
Bosch, Annet M
Treacy, Eileen P
Welt, Corrine K
Berry, Gerard T
Rubio-Gozalbo, M Estela
author_facet van Erven, Britt
Gubbels, Cynthia S
van Golde, Ron J
Dunselman, Gerard A
Derhaag, Josien G
de Wert, Guido
Geraedts, Joep P
Bosch, Annet M
Treacy, Eileen P
Welt, Corrine K
Berry, Gerard T
Rubio-Gozalbo, M Estela
author_sort van Erven, Britt
collection PubMed
description Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there are no recommendations on fertility preservation in this group. The unique pathophysiology of classic galactosemia with a severely reduced follicle pool at an early age requires an adjusted approach. In this article recommendations for physicians based on current knowledge concerning galactosemia and fertility preservation are made. Fertility preservation is only likely to be successful in very young prepubertal patients. In this group, cryopreservation of ovarian tissue is currently the only available technique. However, this technique is not ready for clinical application, it is considered experimental and reduces the ovarian reserve. Fertility preservation at an early age also raises ethical questions that should be taken into account. In addition, spontaneous conception despite POI is well described in classic galactosemia. The uncertainty surrounding fertility preservation and the significant chance of spontaneous pregnancy warrant counseling towards conservative application of these techniques. We propose that fertility preservation should only be offered with appropriate institutional research ethics approval to classic galactosemia girls at a young prepubertal age.
format Online
Article
Text
id pubmed-3718676
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37186762013-07-23 Fertility preservation in female classic galactosemia patients van Erven, Britt Gubbels, Cynthia S van Golde, Ron J Dunselman, Gerard A Derhaag, Josien G de Wert, Guido Geraedts, Joep P Bosch, Annet M Treacy, Eileen P Welt, Corrine K Berry, Gerard T Rubio-Gozalbo, M Estela Orphanet J Rare Dis Review Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there are no recommendations on fertility preservation in this group. The unique pathophysiology of classic galactosemia with a severely reduced follicle pool at an early age requires an adjusted approach. In this article recommendations for physicians based on current knowledge concerning galactosemia and fertility preservation are made. Fertility preservation is only likely to be successful in very young prepubertal patients. In this group, cryopreservation of ovarian tissue is currently the only available technique. However, this technique is not ready for clinical application, it is considered experimental and reduces the ovarian reserve. Fertility preservation at an early age also raises ethical questions that should be taken into account. In addition, spontaneous conception despite POI is well described in classic galactosemia. The uncertainty surrounding fertility preservation and the significant chance of spontaneous pregnancy warrant counseling towards conservative application of these techniques. We propose that fertility preservation should only be offered with appropriate institutional research ethics approval to classic galactosemia girls at a young prepubertal age. BioMed Central 2013-07-16 /pmc/articles/PMC3718676/ /pubmed/23866841 http://dx.doi.org/10.1186/1750-1172-8-107 Text en Copyright © 2013 van Erven et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
van Erven, Britt
Gubbels, Cynthia S
van Golde, Ron J
Dunselman, Gerard A
Derhaag, Josien G
de Wert, Guido
Geraedts, Joep P
Bosch, Annet M
Treacy, Eileen P
Welt, Corrine K
Berry, Gerard T
Rubio-Gozalbo, M Estela
Fertility preservation in female classic galactosemia patients
title Fertility preservation in female classic galactosemia patients
title_full Fertility preservation in female classic galactosemia patients
title_fullStr Fertility preservation in female classic galactosemia patients
title_full_unstemmed Fertility preservation in female classic galactosemia patients
title_short Fertility preservation in female classic galactosemia patients
title_sort fertility preservation in female classic galactosemia patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718676/
https://www.ncbi.nlm.nih.gov/pubmed/23866841
http://dx.doi.org/10.1186/1750-1172-8-107
work_keys_str_mv AT vanervenbritt fertilitypreservationinfemaleclassicgalactosemiapatients
AT gubbelscynthias fertilitypreservationinfemaleclassicgalactosemiapatients
AT vangolderonj fertilitypreservationinfemaleclassicgalactosemiapatients
AT dunselmangerarda fertilitypreservationinfemaleclassicgalactosemiapatients
AT derhaagjosieng fertilitypreservationinfemaleclassicgalactosemiapatients
AT dewertguido fertilitypreservationinfemaleclassicgalactosemiapatients
AT geraedtsjoepp fertilitypreservationinfemaleclassicgalactosemiapatients
AT boschannetm fertilitypreservationinfemaleclassicgalactosemiapatients
AT treacyeileenp fertilitypreservationinfemaleclassicgalactosemiapatients
AT weltcorrinek fertilitypreservationinfemaleclassicgalactosemiapatients
AT berrygerardt fertilitypreservationinfemaleclassicgalactosemiapatients
AT rubiogozalbomestela fertilitypreservationinfemaleclassicgalactosemiapatients